Page last updated: 2024-08-23

vindesine and Ache

vindesine has been researched along with Ache in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosquée, L; D'Odemont, JP; Dams, N; Delobbe, A; Deman, R; Deschepper, K; Dooms, C; Galdermans, D; Nackaerts, K; Siemons, L; Van den Brande, P; Van Kerckhoven, W; Vandebroek, J; Vandeurzen, K; Vansteenkiste, J1
Berdel, WE; Braunheim, M; Heinecke, A; Hoffknecht, P; Klinke, F; Macha, HN; Riesenbeck, D; Schmidt, EW; Schumacher, A; Semik, M; Thomas, M; Wewers, D; Willich, N1
Azzoni, P; Cetto, GL; Genestreti, G; Manno, P; Micciolo, R; Molino, A; Pattaro, C; Santo, A; Sava, T; Terzi, A1
Haas, CD; Hoogstraten, B; Komp, D; Shepherd, DA; Vats, T; Vietti, T1

Reviews

1 review(s) available for vindesine and Ache

ArticleYear
Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.
    Lung cancer (Amsterdam, Netherlands), 2003, Volume: 40, Issue:2

    Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Gemcitabine; Humans; Karnofsky Performance Status; Lung Neoplasms; Pain; Quality of Life; Time Factors; Treatment Outcome; Vindesine

2003

Trials

3 trial(s) available for vindesine and Ache

ArticleYear
Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.
    Lung cancer (Amsterdam, Netherlands), 2003, Volume: 40, Issue:2

    Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Gemcitabine; Humans; Karnofsky Performance Status; Lung Neoplasms; Pain; Quality of Life; Time Factors; Treatment Outcome; Vindesine

2003
Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life.
    Lung cancer (Amsterdam, Netherlands), 2004, Volume: 44, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Dyspnea; Etoposide; Female; Health Status; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Quality of Life; Vindesine

2004
Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients.
    Lung cancer (Amsterdam, Netherlands), 2006, Volume: 53, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Time Factors; Treatment Outcome; Vindesine

2006

Other Studies

1 other study(ies) available for vindesine and Ache

ArticleYear
Phase I evaluation of vindesine in children: a Southwest Oncology Group pilot study.
    Medical and pediatric oncology, 1980, Volume: 8, Issue:3

    Topics: Adolescent; Agranulocytosis; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Humans; Leukemia; Pain; Pilot Projects; Thrombocytopenia; Vinblastine; Vindesine

1980